Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
2012-2022 Report on Global Cancer Treatment Drugs Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
Publication Date Mar 2017
Product Type Report
Pages 116
Single User License help $ 2958.00
Corporate User License help $ 5916.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Summary

In the last several years, Global market of Cancer Treatment Drugs developed rapidly, with an average growth rate of 8.56%. In 2015, Global revenue of Cancer Treatment Drugs is nearly 107 billion USD.

This report studies Cancer Treatment Drugs in Global market, especially in North America, Europe, Japan, Asia (ex. Japan), focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
Bristol-Myers Squibb
Takeda
Eli Lilly
Pfizer
AstraZeneca
Astellas
Sanofi
Bayer
Merck & Co.
Biogen Idec
Kyowa Hakko Kirin
Otsuka
Teva
Eisai
Merck KGaA
Ipsen
AbbVie
Gilead Sciences

Market Segment by Regions, this report splits Global into several key Regions, with revenue, consumption, market share and growth rate of Cancer Treatment Drugs in these regions, from 2011 to 2021 (forecast), like
North America
Europe
Japan
China
India
Southeast Asia
RoW

Split by Product Types, with revenue, market share and growth rate of each type, can be divided into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others

Split by applications, this report focuses on consumption, market share and growth rate of Cancer Treatment Drugs in each application, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

Table of Contents

1 Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Cancer Treatment Drugs Segment by Types
1.2.1 Global Revenue Market Share of Cancer Treatment Drugs by Types in 2015
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.3 Cancer Treatment Drugs Segment by Applications
1.3.1 Cancer Treatment Drugs Consumption Market Share by Applications in 2015
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.4 Cancer Treatment Drugs Market by Regions
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 Japan Status and Prospect (2011-2021)
1.4.4 Asia (ex. Japan) Status and Prospect (2011-2021)
1.5 Global Market Size of Cancer Treatment Drugs (2011-2021)
1.6 Market Drivers and Opportunities
1.6.1 Trends of Oncology Treatment
1.6.2 Emerging Markets/Countries
2 Cancer Treatment Drugs Back Ground Introduction
2.1 Global Cancer Treatment Drugs Back Ground Introduction
2.2 North America Cancer Treatment Drugs Back Ground Introduction
2.3 EMEA Cancer Treatment Drugs Back Ground Introduction
2.4 Asia-Pacific Cancer Treatment Drugs Back Ground Introduction
3 Global Cancer Treatment Drugs Market Competition by Manufacturers
3.1 Global Cancer Treatment Drugs Revenue and Market Share by Manufacturers (2015 and 2016)
3.2 Global Cancer Treatment Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 Manufacturers Cancer Treatment Drugs Headquarters, Founding Date, Main Brands
3.3 Cancer Treatment Drugs Top Brand Analysis
4 Global Cancer Treatment Drugs Revenue by Regions (2012-2017)
4.1 Global Cancer Treatment Drugs Revenue and Market Share by Regions (2012-2017)
4.2 Global Cancer Treatment Drugs Revenue, Cost, Gross and Gross Margin (2012-2017)
4.3 North America Cancer Treatment Drugs Revenue, Cost, Gross and Gross Margin (2012-2017)
4.4 Europe Cancer Treatment Drugs Revenue, Cost, Gross and Gross Margin (2012-2017)
4.5 Japan Cancer Treatment Drugs Revenue, Cost, Gross and Gross Margin (2012-2017)
4.6 Asia (ex. Japan) Cancer Treatment Drugs Revenue, Cost, Gross and Gross Margin (2012-2017)
5 Global Cancer Treatment Drugs Consumption, Export, Import by Regions (2012-2017)
5.1 Global Cancer Treatment Drugs Consumption by Regions (2012-2017)
5.2 North America Cancer Treatment Drugs Export & Import by Regions (2012-2017)
5.3 Europe Cancer Treatment Drugs Export & Import by Regions (2012-2017)
5.4 Japan Cancer Treatment Drugs Export & Import by Regions (2012-2017)
5.5 Asia (ex. Japan) Cancer Treatment Drugs Export & Import by Regions (2012-2017)
6 Global Cancer Treatment Drugs Market Analysis by Types
6.1 Global Cancer Treatment Drugs Revenue and Market Share by Types (2012-2017)
6.2 Global Cancer Treatment Drugs Revenue Growth Rate by Type (2012-2017)
7 Global Cancer Treatment Drugs Market Analysis by Applications
7.1 Global Cancer Treatment Drugs Consumption and Market Share by Application (2012-2017)
7.2 Global Cancer Treatment Drugs Consumption Value Growth Rate by Application (2012-2017)
8 Analysis of Cancer Treatment Drugs Industry Key Manufacturers
8.1 Roche
8.1.1 Company Profile
8.1.2 Product Information
8.1.3 Revenue, Cost, Gross and Gross Margin
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Information
8.2.3 Revenue, Cost, Gross and Gross Margin
8.3 Celgene
8.3.1 Company Profile
8.3.2 Product Information
8.3.3 Revenue, Cost, Gross and Gross Margin
8.4 Amgen
8.4.1 Company Profile
8.4.2 Product Information
8.4.3 Revenue, Cost, Gross and Gross Margin
8.5 Johnson & Johnson
8.5.1 Company Profile
8.5.2 Product Information
8.5.3 Revenue, Cost, Gross and Gross Margin
8.6 Bristol-Myers Squibb
8.6.1 Company Profile
8.6.2 Product Information
8.6.3 Revenue, Cost, Gross and Gross Margin
8.7 Takeda
8.7.1 Company Profile
8.7.2 Product Information
8.7.3 Revenue, Cost, Gross and Gross Margin
8.8 Eli Lilly
8.8.1 Company Profile
8.8.2 Product Information
8.8.3 Revenue, Cost, Gross and Gross Margin
8.9 Pfizer
8.9.1 Company Profile
8.9.2 Product Information
8.9.3 Revenue, Cost, Gross and Gross Margin
8.10 AstraZeneca
8.10.1 Company Profile
8.10.2 Product Information
8.10.3 Revenue, Cost, Gross and Gross Margin
8.11 Astellas
8.11.1 Company Profile
8.11.2 Product Information
8.11.3 Revenue, Cost, Gross and Gross Margin
8.12 Sanofi
8.12.1 Company Profile
8.12.2 Product Information
8.12.3 Revenue, Cost, Gross and Gross Margin
8.13 Bayer
8.13.1 Company Profile
8.13.2 Product Information
8.13.3 Revenue, Cost, Gross and Gross Margin
8.14 Merck & Co.
8.14.1 Company Profile
8.14.2 Product Information
8.14.3 Revenue, Cost, Gross and Gross Margin
8.15 Biogen Idec
8.15.1 Company Profile
8.15.2 Product Information
8.15.3 Revenue, Cost, Gross and Gross Margin
8.16 Kyowa Hakko Kirin
8.16.1 Company Profile
8.16.2 Product Information
8.16.3 Revenue, Cost, Gross and Gross Margin
8.17 Otsuka
8.17.1 Company Profile
8.17.2 Product Information
8.17.3 Revenue, Cost, Gross and Gross Margin
8.18 Teva
8.18.1 Company Profile
8.18.2 Product Information
8.18.3 Revenue, Cost, Gross and Gross Margin
8.19 Eisai
8.19.1 Company Profile
8.19.2 Product Information
8.19.3 Revenue, Cost, Gross and Gross Margin
8.20 Merck KGaA
8.20.1 Company Profile
8.20.2 Product Information
8.20.3 Revenue, Cost, Gross and Gross Margin
8.21 Ipsen
8.21.1 Company Profile
8.21.2 Product Information
8.21.3 Revenue, Cost, Gross and Gross Margin
8.22 AbbVie
8.22.1 Company Profile
8.22.2 Product Information
8.22.3 Revenue, Cost, Gross and Gross Margin
8.23 Gilead Sciences
8.23.1 Company Profile
8.23.2 Product Information
8.23.3 Revenue, Cost, Gross and Gross Margin
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 New Active Substance Launches 2011-2015 by Indication
9.1.2 Rapid Uptake of New Immune-oncology Drugs Reflects Their Remarkable Clinical Profile and Expansion of Indications
9.1.3 Technology Progress in Related Industry
9.2 Cancer Patients Analysis
9.3 Economic/Political Environmental Change
9.4 Health Expenditure Analysis
10 Industrial Chain, Sourcing Strategy and Downstream Buyers
10.1 Cancer Treatment Drugs Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Downstream Buyers
11 Marketing Strategy Analysis, Distributors/Traders
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
11.2.1 Pricing Strategy
11.2.2 Brand Strategy
11.2.3 Target Client
11.3 Distributors/Traders List
12 Global Cancer Treatment Drugs Market Forecast (2017-2022)
12.1 Global Cancer Treatment Drugs Revenue Forecast (2017-2022)
12.2 Global Cancer Treatment Drugs Revenue, Consumption Forecast by Regions (2017-2022)
12.3 Global Cancer Treatment Drugs Revenue Forecast by Type (2017-2022)
12.4 Global Cancer Treatment Drugs Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Author List
Source List
Disclosure Section
Research Methodology
Data Source
Disclaimer



List of Figures
List of Tables and Figures

Figure Picture of Cancer Treatment Drugs
Table Classification of Cancer Treatment Drugs
Figure Global Revenue Market Share of Cancer Treatment Drugs by Types in 2015
Figure Product Picture of Chemotherapy
Figure Product Picture of Targeted Therapy
Figure Product Picture of Immunotherapy (Biologic Therapy)
Figure Product Picture of Hormonal Therapy
Table Applications of Cancer Treatment Drugs
Table Cancer Treatment Drugs Consumption Value Market Share by Applications in 2015
Figure Blood Cancer Examples
Figure Breast Cancer Examples
Figure Gastrointestinal Cancer Examples
Figure Prostate Cancer Examples
Figure Respiratory/Lung Cancer Examples
Figure North America Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Europe Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Japan Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Asia (ex. Japan) Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Global Cancer Treatment Drugs Revenue (M USD) and Growth Rate (2011-2021)
Figure Cancer Incidence by Country in 2015
Figure Cancer Mortality by Country in 2015
Figure USA numbers of new cancer cases for 2015
Figure Canada numbers of new cancer cases for 2015
Figure EU numbers of new cancer cases for 2015
Figure Med- East numbers of new cancer cases for 2015
Figure Africa numbers of new cancer cases for 2015
Figure China numbers of new cancer cases for 2015
Figure Japan numbers of new cancer cases for 2015
Figure South East Asia numbers of new cancer cases for 2015
Table Global Cancer Treatment Drugs Revenue (M USD) of Key Manufacturers (2015 and 2016)
Table Global Cancer Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Treatment Drugs Revenue Market Share by Manufacturers
Figure 2016 Cancer Treatment Drugs Revenue Market Share by Manufacturers
Table Global Cancer Treatment Drugs Gross Margin by Manufacturers (2015 and 2016)
Figure 2015 Global Cancer Treatment Drugs Gross Margin by Manufacturers
Figure 2016 Global Cancer Treatment Drugs Gross Margin by Manufacturers
Table 2016 Global Cancer Treatment Drugs Gross (M USD) by Manufacturers
Figure 2015 Global Cancer Treatment Drugs Gross by Manufacturers
Figure 2016 Global Cancer Treatment Drugs Gross by Manufacturers
Table Manufacturers Cancer Treatment Drugs Headquarters and Founded Date
Table Manufacturers Cancer Treatment Drugs Main Brands
Table Cancer Treatment Drugs Top 10 brand, Manufacturers and Revenue in 2016
Table Global Cancer Treatment Drugs Revenue (M USD) by Regions (2012-2017)
Table Global Cancer Treatment Drugs Revenue Market Share by Regions (2012-2017)
Figure 2015 Global Cancer Treatment Drugs Revenue Market Share by Regions
Figure 2016 Global Cancer Treatment Drugs Revenue Market Share by Regions
Table Global Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table North America Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Europe Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Japan Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Asia (ex. Japan) Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value (M USD) Market by Regions (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value Market Share by Regions (2012-2017)
Figure Global Cancer Treatment Drugs Consumption Value Market Share by Regions (2012-2017)
Figure 2015 Global Cancer Treatment Drugs Consumption Value Market Share by Regions
Figure 2016 Global Cancer Treatment Drugs Consumption Value Market Share by Regions
Figure North America Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure Europe Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure Japan Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure China Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure India Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Figure Southeast Asia Cancer Treatment Drugs Consumption Value (M USD) and Growth Rate (2011-2021)
Table North America Cancer Treatment Drugs Import & Export (2012-2017)
Table Europe Cancer Treatment Drugs Import & Export (2012-2017)
Table Japan Cancer Treatment Drugs Import & Export (2012-2017)
Table Asia (ex. Japan) Cancer Treatment Drugs Import & Export (2012-2017)
Table Global Cancer Treatment Drugs Revenue (M USD) by Types (2012-2017)
Table Global Cancer Treatment Drugs Revenue Share by Types (2012-2017)
Figure Revenue Market Share of Cancer Treatment Drugs by Types (2012-2017)
Figure 2015 Revenue Market Share of Cancer Treatment Drugs by Types
Figure 2016 Revenue Market Share of Cancer Treatment Drugs by Types
Figure Global Cancer Treatment Drugs Revenue Growth by Type (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value (M USD) by Application (2012-2017)
Table Global Cancer Treatment Drugs Consumption Value Market Share by Application (2012-2017)
Figure Global Cancer Treatment Drugs Consumption Value Market Share by Application in 2015
Figure 2015 Consumption Value Market Share by Application (2012-2017)
Figure 2016 Consumption Value Market Share by Application (2012-2017)
Table Global Cancer Treatment Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Treatment Drugs Consumption Value Growth Rate by Application (2012-2017)
Table Roche Company Profile
Figure Cancer Treatment Drugs Product Picture of Roche
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Roche 2015-2016
Table Novartis Company Profile
Figure Cancer Treatment Drugs Product Picture of Novartis
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Novartis 2015-2016
Table Celgene Company Profile
Figure Cancer Treatment Drugs Product Picture of Celgene
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Celgene 2015-2016
Table Amgen Company Profile
Figure Cancer Treatment Drugs Product Picture of Amgen
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Amgen 2015-2016
Table Johnson & Johnson Company Profile
Figure Cancer Treatment Drugs Product Picture of Johnson & Johnson
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Johnson & Johnson 2015-2016
Table Bristol-Myers Squibb Company Profile
Figure Cancer Treatment Drugs Product Picture of Bristol-Myers Squibb
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bristol-Myers Squibb 2015-2016
Table Takeda Company Profile
Figure Cancer Treatment Drugs Product Picture of Takeda
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Takeda 2015-2016
Table Eli Lilly Company Profile
Figure Cancer Treatment Drugs Product Picture of Eli Lilly
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eli Lilly 2015-2016
Table Pfizer Company Profile
Figure Cancer Treatment Drugs Product Picture of Pfizer
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Pfizer 2015-2016
Table AstraZeneca Company Profile
Figure Cancer Treatment Drugs Product Picture of AstraZeneca
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of AstraZeneca 2015-2016
Table Astellas Company Profile
Figure Cancer Treatment Drugs Product Picture of Astellas
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Astellas 2015-2016
Table Sanofi Company Profile
Figure Cancer Treatment Drugs Product Picture of Sanofi
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Sanofi 2015-2016
Table Bayer Company Profile
Figure Cancer Treatment Drugs Product Picture of Bayer
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Bayer 2015-2016
Table Merck & Co. Company Profile
Figure Cancer Treatment Drugs Product Picture of Merck & Co.
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck & Co. 2015-2016
Table Biogen Idec Company Profile
Figure Cancer Treatment Drugs Product Picture of Biogen Idec
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Biogen Idec 2015-2016
Table Kyowa Hakko Kirin Company Profile
Figure Cancer Treatment Drugs Product Picture of Kyowa Hakko Kirin
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Kyowa Hakko Kirin 2015-2016
Table Otsuka Company Profile
Figure Cancer Treatment Drugs Product Picture of Otsuka
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Otsuka 2015-2016
Table Teva Company Profile
Figure Cancer Treatment Drugs Product Picture of Teva
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Teva 2015-2016
Table Eisai Company Profile
Figure Cancer Treatment Drugs Product Picture of Eisai
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Eisai 2015-2016
Table Merck KGaA Company Profile
Figure Cancer Treatment Drugs Product Picture of Merck KGaA
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Merck KGaA 2015-2016
Table Ipsen Company Profile
Figure Cancer Treatment Drugs Product Picture of Ipsen
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Ipsen 2015-2016
Table AbbVie Company Profile
Figure Cancer Treatment Drugs Product Picture of AbbVie
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of AbbVie 2015-2016
Table Gilead Sciences Company Profile
Figure Cancer Treatment Drugs Product Picture of Gilead Sciences
Table Cancer Treatment Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin of Gilead Sciences 2015-2016
Figure New Active Substance Launches 2011-2015 by Indication
Figure Immuno-Oncology PD-1 Inhibitor Uptake in the U.S.
Figure Growth of the Late Phase Oncology Pipeline, 2005-2015
Figure Key In-Market and Investigational Agents for NSCLC
Figure Key In-Market and Investigational Agents for Melanoma
Figure the Global Late Phase Oncology Pipeline in 2015
Figure Companies with Active Late Phase Oncology Pipelines
Figure Global GDP Map 2016
Figure EU GDP Change 2005-2016
Figure German CPI Change 2011-2015
Figure UK CPI Change 2011-2015
Figure Japan GDP Change 2005-2016
Figure Japan CPI Change 2011-2015
Figure China GDP Change 2005-2016
Figure China CPI Change 20011-2015
Figure China PPI Growth Rate 2011-2015
Figure US GDP Change 2005-2016
Figure US CPI Change 2011-2015
Figure Out-of-pocket Expenditure on Health as a Percentage of Total Expenditure on Health (%) in 2014
Figure Total Expenditure on Health as a Percentage of GDP (%) in 2014
Figure Global Average Health Expenditure, Total (% of GDP)
Table USA Health Expenditure Ratios from 1995-2016
Table China Health Expenditure Ratios from 1995-2016
Table Japan Health Expenditure Ratios from 1995-2016
Table Germany Health Expenditure Ratios from 1995-2016
Table UK Health Expenditure Ratios from 1995-2016
Table India Health Expenditure Ratios from 1995-2016
Table Canada Health Expenditure Ratios from 1995-2016
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Upstream Raw Materials Sourcing
Table Major Buyers of Cancer Treatment Drugs
Figure Marketing Channel for Biopharmaceuticals
Table Some of Famous Hospital
Table Distributors/Traders List
Figure Global Cancer Treatment Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022)
Table Global Cancer Treatment Drugs Revenue (M USD) Forecast by Regions (2017-2022)
Figure North America Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Figure Europe Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Figure Japan Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Figure Asia (ex. Japan) Cancer Treatment Drugs Revenue (M USD) Forecast (2017-2022)
Table Global Cancer Treatment Drugs Consumption Value (M USD) Forecast by Regions (2017-2022)
Figure North America Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure Europe Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure Japan Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure China Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure India Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Figure Southeast Asia Cancer Treatment Drugs Consumption Value (M USD) Forecast (2017-2022)
Table Global Cancer Treatment Drugs Revenue (M USD) Forecast by Type (2017-2022)
Table Global Cancer Treatment Drugs Consumption (Value) Forecast by Application (2017-2022)




Title Date Price
Global Dental Laboratory Handpieces Consumption 2016 Market Research Report
By QYResearch
The Global Dental Laboratory Handpieces Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Dental Laboratory Handpieces market. First, the report ...Read More
Jan 2016 $4000.00
Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices
By Access China Management Consulting Ltd
Now, Chinese regulations on medical devices are undergoing earthshaking changes. China’s new leaders have recognized that the regulations for supervision and administration of medical devices are fa ...Read More
Aug 2014 $1250.00
2012-2022 Report on Global Advanced Wound Care Management Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
Notes: Production, means the output of Advanced Wound Care Management Revenue, means the sales value of Advanced Wound Care Management This report studies Advanced Wound Care Management in Global mar ...Read More
Mar 2017 $2958.00
2012-2022 Report on Global Aliphatic Isocyanates Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
otes: Production, means the output of Aliphatic Isocyanates Revenue, means the sales value of Aliphatic Isocyanates This report studies three types of Aliphatic Isocyanates (HDI, IPDI and H12MDI) in ...Read More
Mar 2017 $2958.00
2012-2022 Report on Global BP Cuff Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
the last several years, global market of BP Cuff developed rapidly, with an average growth rate of 6.52%. In 2016, global revenue of BP Cuff is nearly 985.5 Million USD; the actual production is abou ...Read More
Mar 2017 $2958.00
2012-2022 Report on Global Cancer Treatment Drugs Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
Summary In the last several years, Global market of Cancer Treatment Drugs developed rapidly, with an average growth rate of 8.56%. In 2015, Global revenue of Cancer Treatment Drugs is nearly 107 bil ...Read More
Mar 2017 $2958.00
2012-2022 Report on Global Cobalt oxide Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
Type: Colorants Catalysts Livestock nutrition Adhesives Applications: Paint additives Enamel and ceramic pigments Refined petroleum catalyst Battery industry Other products raw materials Company(G ...Read More
Mar 2017 $2958.00
2012-2022 Report on Global Coextruded Medical Tube Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
This report studies the Coextruded Medical Tube market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top p ...Read More
Mar 2017 $3268.00
2012-2022 Report on Global Hematology Analyzer Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
2017-2022 Global Hematology Analyzer Consumption Market Report is a professional and in-depth study on the current state of the Hematology Analyzer market. First, the report provides a basic overview ...Read More
Mar 2017 $2958.00
2012-2022 Report on Global Neurobiology ELISA Kits Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
By QYResearch
This report studies sales (consumption) of Neurobiology ELISA Kits in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, p ...Read More
Mar 2017 $2958.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  QYResearch

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z